Skip to main content
AXIOS™ Stent over swirling line background.

AXIOS™ Stent

and Electrocautery Enhanced Delivery System

New indication for AXIOS for EUS-guided gallbladder drainage

AXIOS Stent technology is now FDA-cleared for transgastric or transduodenal endoscopic ultrasound (EUS)-guided gallbladder drainage (GBD) in high-risk patients with acute cholecystitis.* When surgery is not an option, EUS-guided GBD is a viable treatment alternative – offering non-surgical candidates effective care that can reduce pain and reinterventions while preserving quality of life. 

How AXIOS Stent technology works

Autotome™ Pro RX Cannulating Sphincterotome product detail.

Manage acute cholecystitis

EUS-guided GBD can provide benefits for patients, clinical teams and hospitals.

Explore benefits

Autotome™ Pro RX Cannulating Sphincterotome product detail.

Proven technology

Learn why AXIOS stent technology is safe and effective. 

Explore features

Connect with your rep

Learn more about AXIOS Stent technology and the benefits of EUS-guided GBD.

Not sure who your rep is? Complete the request a rep form.

*The 10mm×10mm and 15mm×10mm AXIOS Stent and Electrocautery-Enhanced Delivery System devices are cleared in the US to facilitate transgastric or transduodenal endoscopic drainage of the gallbladder in patients with acute cholecystitis who are at high risk for surgery. 

CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings and instructions for use can be found in the product labeling supplied with each device or at Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material is not intended for use in France. Rx Only.